NovaGo Therapeutics closes $30M Series B for spinal cord injury trial / Bio-Technopark Schlieren-Zürich / beUnity

NovaGo Therapeutics closes $30M Series B for spinal cord injury trial

In English
Auf Deutsch

Bio-Technopark Schlieren-Zürich Offizielles